Intakes of vitamins E and C, carotenoids, vitamin supplements, and PD risk.

PubWeight™: 1.75‹?› | Rank: Top 3%

🔗 View Article (PMID 12391343)

Published in Neurology on October 22, 2002

Authors

S M Zhang1, M A Hernán, H Chen, D Spiegelman, W C Willett, A Ascherio

Author Affiliations

1: Department of Nutrition, Harvard School of Public Health, 665 Huntington Avenue, Boston, MA 02115, USA. Shumin.Zhang@channing.harvard.edu

Articles citing this

Vitamin C function in the brain: vital role of the ascorbate transporter SVCT2. Free Radic Biol Med (2009) 1.94

Antioxidants in central nervous system diseases: preclinical promise and translational challenges. J Alzheimers Dis (2008) 1.88

Prospective study of dietary pattern and risk of Parkinson disease. Am J Clin Nutr (2007) 1.57

Redox proteomics in selected neurodegenerative disorders: from its infancy to future applications. Antioxid Redox Signal (2012) 1.24

Current approaches to the treatment of Parkinson's disease. Neuropsychiatr Dis Treat (2008) 1.19

The Role of Oxidative Stress in Neurodegenerative Diseases. Exp Neurobiol (2015) 1.16

Differential effects of black versus green tea on risk of Parkinson's disease in the Singapore Chinese Health Study. Am J Epidemiol (2007) 1.15

Physical activity and risk of Parkinson's disease: a prospective cohort study. J Neurol Neurosurg Psychiatry (2006) 1.06

Mitochondria-targeted antioxidants for treatment of Parkinson's disease: preclinical and clinical outcomes. Biochim Biophys Acta (2013) 1.04

The promise of neuroprotective agents in Parkinson's disease. Front Neurol (2011) 0.96

Meeting report: consensus statement-Parkinson's disease and the environment: collaborative on health and the environment and Parkinson's Action Network (CHE PAN) conference 26-28 June 2007. Environ Health Perspect (2008) 0.94

Mitochondrial medicine for neurodegenerative diseases. Int J Biochem Cell Biol (2010) 0.93

The association between Mediterranean diet adherence and Parkinson's disease. Mov Disord (2012) 0.88

The role of lipid peroxidation in neurological disorders. J Clin Biochem Nutr (2014) 0.88

Dementia with Lewy bodies: Definition, diagnosis, and pathogenic relationship to Alzheimer's disease. Neuropsychiatr Dis Treat (2007) 0.88

Edaravone guards dopamine neurons in a rotenone model for Parkinson's disease. PLoS One (2011) 0.88

Dietary iron intake and risk of Parkinson's disease. Am J Epidemiol (2008) 0.87

Targeting the progression of Parkinson's disease. Curr Neuropharmacol (2009) 0.82

Dietary factors in the etiology of Parkinson's disease. Biomed Res Int (2015) 0.81

Enhancing case ascertainment of Parkinson's disease using Medicare claims data in a population-based cohort: the Cardiovascular Health Study. Pharmacoepidemiol Drug Saf (2013) 0.79

Nutraceuticals in Parkinson's Disease. Neuromolecular Med (2016) 0.76

Vitamins and the risk for Parkinson's disease. Neurology (2002) 0.76

Intake of antioxidant vitamins and risk of Parkinson's disease. Mov Disord (2016) 0.75

Micronutrients and Risk of Parkinson's Disease: A Systematic Review. Gerontol Geriatr Med (2016) 0.75

Rice Bran Dietary Supplementation Improves Neurological Symptoms and Loss of Purkinje Cells in Vitamin E-Deficient Mice. Yonago Acta Med (2016) 0.75

The role of VDR and BIM in potentiation of cytarabine-induced cell death in human AML blasts. Oncotarget (2016) 0.75

Is Ginkgo biloba and/or a Multivitamin-multimineral Supplement a Therapeutic Option for Parkinson's Disease? A Case Report. Glob Adv Health Med (2014) 0.75

Nutrition and the risk for Parkinson's disease: review of the literature. J Neural Transm (Vienna) (2008) 0.75

Anti-Oxidants in Parkinson's Disease Therapy: A Critical Point of View. Curr Neuropharmacol (2016) 0.75

Association of serum carotenoid, retinol, and tocopherol concentrations with the progression of Parkinson's Disease. Nutr Res Pract (2016) 0.75

Molecular Mechanisms Underlying Protective Effects of Quercetin Against Mitochondrial Dysfunction and Progressive Dopaminergic Neurodegeneration in Cell Culture and MitoPark Transgenic Mouse Models of Parkinson's Disease. J Neurochem (2017) 0.75

D-512, a novel dopamine D2 / D3 receptor agonist, demonstrates superior anti-parkinsonian efficacy over ropinirole in parkinsonian rats. Br J Pharmacol (2017) 0.75

Targeting urate to reduce oxidative stress in Parkinson disease. Exp Neurol (2017) 0.75

Articles by these authors

Marginal structural models and causal inference in epidemiology. Epidemiology (2000) 33.54

Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol (1985) 26.13

Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol (1992) 17.17

Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature (1996) 16.92

Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia. Nature (2004) 16.76

Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med (2001) 14.48

The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med (1995) 11.08

Body weight and mortality among women. N Engl J Med (1995) 11.04

Food-based validation of a dietary questionnaire: the effects of week-to-week variation in food consumption. Int J Epidemiol (1989) 10.98

Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol (1986) 10.84

Validity of self-reported waist and hip circumferences in men and women. Epidemiology (1990) 10.57

Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet (1998) 10.11

Reproducibility and validity of a self-administered physical activity questionnaire. Int J Epidemiol (1994) 9.90

Reproducibility and validity of food intake measurements from a semiquantitative food frequency questionnaire. J Am Diet Assoc (1993) 9.90

Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S. Diabetes Care (2001) 9.76

Aspirin and the risk of colorectal cancer in women. N Engl J Med (1995) 9.59

Dietary fat and coronary heart disease: a comparison of approaches for adjusting for total energy intake and modeling repeated dietary measurements. Am J Epidemiol (1999) 9.34

Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med (2000) 9.05

Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. N Engl J Med (1991) 8.66

Prospective study of alcohol consumption and risk of coronary disease in men. Lancet (1991) 8.64

Test of the National Death Index. Am J Epidemiol (1984) 8.46

Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med (1997) 8.43

Misinterpretation and misuse of the kappa statistic. Am J Epidemiol (1987) 8.29

Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders. Cancer Res (1997) 7.95

Physical activity and incidence of non-insulin-dependent diabetes mellitus in women. Lancet (1991) 7.87

Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med (1995) 7.62

Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction. JAMA (1997) 7.42

Role of domestic ducks in the propagation and biological evolution of highly pathogenic H5N1 influenza viruses in Asia. Proc Natl Acad Sci U S A (2005) 7.12

Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care (1994) 7.11

Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA (1998) 7.09

Reproducibility and validity of dietary patterns assessed with a food-frequency questionnaire. Am J Clin Nutr (1999) 7.02

Plasma organochlorine levels and the risk of breast cancer. N Engl J Med (1997) 7.02

Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women. JAMA (1997) 6.92

The effect of fruit and vegetable intake on risk for coronary heart disease. Ann Intern Med (2001) 6.37

Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med (1993) 6.37

Physical activity and television watching in relation to risk for type 2 diabetes mellitus in men. Arch Intern Med (2001) 6.23

Prospective study of body mass index, weight change, and risk of adult-onset asthma in women. Arch Intern Med (1999) 6.21

Abdominal adiposity and coronary heart disease in women. JAMA (1998) 6.21

Dietary fiber and the risk of colorectal cancer and adenoma in women. N Engl J Med (1999) 6.17

A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med (1991) 6.13

A prospective study of family history and the risk of colorectal cancer. N Engl J Med (1994) 6.12

A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med (1990) 6.06

Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst (2001) 5.97

Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci U S A (1995) 5.92

Requirement for neuregulin receptor erbB2 in neural and cardiac development. Nature (1995) 5.91

A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med (1993) 5.87

Are ducks contributing to the endemicity of highly pathogenic H5N1 influenza virus in Asia? J Virol (2005) 5.78

Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell (1998) 5.78

Association between dietary patterns and plasma biomarkers of obesity and cardiovascular disease risk. Am J Clin Nutr (2001) 5.67

The assessment of alcohol consumption by a simple self-administered questionnaire. Am J Epidemiol (1991) 5.60

Physical activity, obesity, and risk for colon cancer and adenoma in men. Ann Intern Med (1995) 5.42

Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med (1994) 5.42

Vitamin E consumption and the risk of coronary disease in women. N Engl J Med (1993) 5.39

Lactation and a reduced risk of premenopausal breast cancer. N Engl J Med (1994) 5.37

Genetic diversity and disease control in rice. Nature (2000) 5.34

Rotating night shifts and risk of breast cancer in women participating in the nurses' health study. J Natl Cancer Inst (2001) 5.33

Tubal ligation, hysterectomy, and risk of ovarian cancer. A prospective study. JAMA (1993) 5.31

A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med (2000) 5.17

Prospective study of major dietary patterns and risk of coronary heart disease in men. Am J Clin Nutr (2000) 5.17

A prospective cohort study of vasectomy and prostate cancer in US men. JAMA (1993) 5.09

Congenital deafness and sinoatrial node dysfunction in mice lacking class D L-type Ca2+ channels. Cell (2000) 5.08

Correction of logistic regression relative risk estimates and confidence intervals for systematic within-person measurement error. Stat Med (1989) 5.08

Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates. Cell (1999) 5.07

Birthweight as a risk factor for breast cancer. Lancet (1996) 5.05

Postmenopausal hormone therapy and mortality. N Engl J Med (1997) 4.96

Crystal structure of a TFIIB-TBP-TATA-element ternary complex. Nature (1995) 4.93

Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet Gynecol (1997) 4.84

Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol (2000) 4.83

Dual effects of weight and weight gain on breast cancer risk. JAMA (1997) 4.81

Correction of logistic regression relative risk estimates and confidence intervals for measurement error: the case of multiple covariates measured with error. Am J Epidemiol (1990) 4.80

Dietary fat and fiber in relation to risk of breast cancer. An 8-year follow-up. JAMA (1992) 4.80

NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway. Nat Immunol (2000) 4.75

Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst (1998) 4.74

Menopause and the risk of coronary heart disease in women. N Engl J Med (1987) 4.70

Alcohol and breast cancer in women: a pooled analysis of cohort studies. JAMA (1998) 4.65

Weight as a risk factor for clinical diabetes in women. Am J Epidemiol (1990) 4.64

A prospective study of walking as compared with vigorous exercise in the prevention of coronary heart disease in women. N Engl J Med (1999) 4.61

A prospective study of passive smoking and coronary heart disease. Circulation (1997) 4.51

A prospective study of pregravid determinants of gestational diabetes mellitus. JAMA (1997) 4.50

Birth weight and risk of cardiovascular disease in a cohort of women followed up since 1976. BMJ (1997) 4.49